Characterisation of (R/S)-propafenone and its metabolites as substrates and inhibitors of P-glycoprotein
- 1 March 2005
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 371 (3) , 195-201
- https://doi.org/10.1007/s00210-005-1025-y
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Intramolecular Distribution of Hydrophobicity Influences Pharmacological Activity of Propafenone‐type MDR ModulatorsArchiv der Pharmazie, 2004
- A Subset of Highly Effective Propafenone-Type Multidrug Resistance Modulators Lacks Effects on Cardiac Action Potential and Mechanical Twitch Parameters of Rat Papillary MusclesThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- PropafenoneDrugs, 1993
- Serum Digoxin Levels Related to Plasma Propafenone Levels During Concomitant TreatmentThe Journal of Clinical Pharmacology, 1991
- Interaction between digoxin and propafenone in childrenThe Journal of Pediatrics, 1990
- PropafenoneNew England Journal of Medicine, 1990
- Effects of Coadministration of Propafenone on the Pharmacokinetics of Digoxin in Healthy Volunteer SubjectsThe Journal of Clinical Pharmacology, 1989
- A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexesThe American Journal of Cardiology, 1983
- Quinidine-Digoxin InteractionNew England Journal of Medicine, 1979